Illumina To Webcast Upcoming Investor Conference
Illumina (NASDAQ: ILMN) announced its participation in the Cowen Health Care Conference on March 7, 2022. The company's executives will engage in a fireside chat scheduled for 11:50 AM Pacific Time (2:50 PM Eastern Time), which will be accessible via a live webcast on Illumina's website. A replay will be available for at least 30 days post-event. Illumina is a leader in DNA sequencing and related technologies, aiming to enhance human health through genomic innovation.
- None.
- None.
SAN DIEGO, Feb. 21, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
- Cowen Health Care Conference on March 7, 2022
Fireside Chat at 11:50am Pacific Time (2:50pm Eastern Time)
The live webcast can be accessed under the Investor Info section of Illumina's website under the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Sarah Shew
+1.330.353.2512
sshew@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301486726.html
SOURCE Illumina, Inc.
FAQ
What is the date and time of Illumina's fireside chat at the Cowen Health Care Conference?
Where can I watch the webcast of Illumina's conference presentation?
How long will Illumina's conference replay be available?
What is Illumina's focus in the healthcare industry?